PNC Financial Services Group Inc. Decreases Stake in Roche Holding AG (OTCMKTS:RHHBY)

PNC Financial Services Group Inc. reduced its stake in Roche Holding AG (OTCMKTS:RHHBY) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,911 shares of the company’s stock after selling 751 shares during the period. PNC Financial Services Group Inc.’s holdings in Roche were worth $555,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of RHHBY. Brooklyn Investment Group purchased a new position in shares of Roche during the third quarter valued at approximately $40,000. IHT Wealth Management LLC purchased a new position in shares of Roche during the third quarter valued at approximately $236,000. Verity Asset Management Inc. increased its stake in shares of Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock valued at $280,000 after buying an additional 1,697 shares during the period. Canopy Partners LLC increased its stake in shares of Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares during the period. Finally, Confluence Investment Management LLC increased its stake in shares of Roche by 26.3% during the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after buying an additional 2,910 shares during the period.

Roche Stock Down 1.6 %

Shares of OTCMKTS:RHHBY opened at $43.36 on Thursday. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $44.31. The stock’s fifty day moving average price is $40.27 and its 200-day moving average price is $38.57.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on RHHBY shares. Morgan Stanley started coverage on Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating on the stock. UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Finally, Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Roche currently has an average rating of “Moderate Buy”.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.